Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-12-08FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) by IBSA Pharma Inc., updating the product labeling as part o…
-
FDA approval · 2017-12-05FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved a supplemental application for levothyroxine sodium submitted by Lannett Company, Inc.
-
CLINICAL_TRIALS withdrawal · 2017-10-06Clinical Trial Update: Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
A National Institute of Diabetes and Digestive and Kidney Diseases sponsored trial investigating the effects of thyroid hormone enzyme block…
-
FDA label_change · 2017-08-31FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
The FDA approved a supplemental application for Levothyroxine Sodium from Alvogen, Inc., resulting in labeling changes for the product.
-
CLINICAL_TRIALS research · 2017-08-28Clinical Trial Update: Effect of Hypothyroidism on Brown Adipose Tissue
A completed clinical trial investigating the effect of hypothyroidism on brown adipose tissue.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Hypothyroidism in Patients With Type 1 Diabetes
This clinical trial update discusses hypothyroidism in patients with type 1 diabetes, with the current trial status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Non-immune Related Hypothyroidism in Iodine Sufficient Area
A completed clinical trial update concerning non-immune related hypothyroidism in an iodine-sufficient area.
-
CLINICAL_TRIALS research · 2017-06-07Clinical Trial Update: Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy
This clinical trial update reports on hypothyroidism in patients with type 2 diabetes and early diabetic nephropathy. It is an ongoing study…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental Implications
This clinical trial update describes reduced thyroid function in premature newborns and investigates how placental molecular changes and mat…
-
FDA approval · 2017-04-25FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) submitted by IBSA Pharma Inc.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
This completed clinical trial update examines whether subclinical thyroid dysfunction is associated with increased risk of myocardial infarc…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics [EARLY_Phase 1]
An early-phase study evaluating how age, weight, and sex influence levothyroxine pharmacokinetics in individuals with hypothyroidism.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients [NA]
A completed clinical trial evaluated the interaction between levothyroxine and probiotic supplements in patients with hypothyroidism.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: The TRUST Study - CardioVascular Imaging IMT [Phase 4]
The TRUST study, a Phase 4 trial evaluating CardioVascular Imaging IMT, has completed.
-
FDA approval · 2017-02-24FDA Approved: TIROSINT SOL — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT SOL (levothyroxine sodium) from IBSA Pharma Inc., a thyroid hormone replacement the…
-
FDA label_change · 2017-02-23FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a labeling supplement for Synthroid (levothyroxine sodium) submitted by AbbVie, updating the drug’s labeling.
-
FDA approval · 2017-01-12FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
The FDA approved a supplemental application for Levothyroxine Sodium from Lannett Company, Inc, enabling the marketed generic product.
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Thyroid Hormone Dose Adjustment in Pregnancy [NA]
A completed Brigham and Women's Hospital trial evaluated adjusting thyroid hormone doses during pregnancy in women with hypothyroidism; resu…
-
FDA approval · 2016-12-15FDA Approved: TIROSINT SOL — Original Application (IBSA Pharma Inc.)
FDA approved TIROSINT SOL (levothyroxine sodium) from IBSA Pharma Inc. in an original NDA, introducing a new brand/formulation of thyroid ho…
-
CLINICAL_TRIALS research · 2016-10-18Clinical Trial Update: Thyroid Disorders in Malaysia: A Nationwide Multicentre Study
A completed nationwide multicentre study in Malaysia evaluating the spectrum of thyroid disorders, including hypothyroidism and hyperthyroid…
-
CLINICAL_TRIALS research · 2016-09-28Clinical Trial Update: Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism [Phase 4]
A phase 4 randomized crossover trial evaluates the potential effects of two different oral formulations of levothyroxine in adults with prim…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List [NA]
Completed clinical trial evaluating the effects of teleconsultations on an endocrinology referral list for diabetes and thyroid-related cond…
-
FDA approval · 2016-06-29FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Piramal Critical Care, Inc.)
FDA approved Piramal Critical Care's levothyroxine sodium as an original application (ANDA206163), providing a generic option for thyroid ho…
-
FDA approval · 2016-05-19FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
The FDA approved a supplemental application for levothyroxine sodium submitted by Alvogen, Inc., indicating an approved change to an existin…
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Immunogenetic Factors of Coronary Heart Disease
This completed NHLBI-supported study investigates how immunogenetic factors influence the risk of coronary heart disease.